DATASHEET
Host:
Rabbit
Target Protein:
Phospho-delta Opioid Receptor (Ser363)
Specificity:
This phosphorylation site is homologous in the listed cross reactive species at the specified location.
Modification Site:
Ser363
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
4985
Swiss Prot:
P41143
Source:
KLH conjugated synthetic peptide derived from human OPRD1 around the phosphorylation site of TP(p-S)DG
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
Background:
G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine.
VALIDATION IMAGES
Formalin-fixed and paraffin embedded human neurological glioblastoma labeled with Anti-OPRD1 (Ser363) Polyclonal Antibody, Unconjugated (bs-20197R) at 1:200 followed by conjugation to the secondary antibody and DAB staining.
Formalin-fixed and paraffin embedded human Neurological glioblastoma labeled with Anti-OPRD1 (Ser363) Polyclonal Antibody, Unconjugated (bs-20197R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
Paraformaldehyde-fixed, paraffin embedded rat brain tissue; Antigen retrieval by boiling in sodium citrate buffer(pH6) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 30 minutes; Blocking buffer (normal goat serum) at 37°C for 20min; Antibody incubation with Rabbit Anti-OPRD1 (Ser363) Polyclonal Antibody, Unconjugated (bs-20197R) at 1:500 overnight at 4°C, followed by a conjugated secondary and DAB staining
Lane 1: Mouse Cerebrum tissue lysates; Lane 2: Mouse Cerebellum tissue lysates; Lane 3: Rat Cerebrum tissue lysates; Lane 4: Rat Cerebellum tissue lysates probed with Phospho-delta Opioid Receptor (Ser363) Polyclonal Antibody, Unconjugated (bs-20197R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.